Trials / Completed
CompletedNCT00082485
Baclofen for the Treatment of Cocaine Dependence - 1
Multi-Center Trial of Baclofen for the Treatment of Cocaine Dependence
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 160 (actual)
- Sponsor
- National Institute on Drug Abuse (NIDA) · NIH
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the efficacy and safety of baclofen for the treatment of cocaine dependence.
Detailed description
Double-blind, placebo-controlled, parallel design trial of baclofen for the treatment of cocaine dependence
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Baclofen | Dose escalation 10-60mg (week 1) 60 mg (weeks 2-7) Dose taper (week 8) |
| OTHER | Placebo | Placebo |
Timeline
- Start date
- 2004-06-01
- Primary completion
- 2006-07-01
- First posted
- 2004-05-12
- Last updated
- 2017-01-12
Locations
8 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00082485. Inclusion in this directory is not an endorsement.